Paratek Pharmaceuticals Inc

Baird Financial Group, Inc.

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/11/2023

Shares

10,435

Value ($000)

23

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/11/2023	23	0.0%	10,435	6/30/2023
2023 Q1	5/15/2023	90	0.0%	35,500	3/31/2023
2022 Q4	2/13/2023	66	0.0%	35,500	12/31/2022
2022 Q3	11/15/2022	126	0.0%	49,070	9/30/2022
2022 Q2	8/8/2022	84	0.0%	43,500	6/30/2022
2022 Q1	5/13/2022	134	0.0%	45,175	3/31/2022
2021 Q4	2/9/2022	200	0.0%	44,625	12/31/2021
2021 Q3	11/12/2021	246	0.0%	50,525	9/30/2021
2021 Q2	8/11/2021	357	0.0%	52,405	6/30/2021
2021 Q1	5/13/2021	366	0.0%	51,905	3/31/2021
2020 Q4	2/11/2021	325	0.0%	51,905	12/31/2020
2020 Q3	11/12/2020	291	0.0%	53,805	9/30/2020
2020 Q2	10/22/2020	289	0.0%	55,305	6/30/2020
2020 Q1	5/14/2020	158	0.0%	50,005	3/31/2020
2019 Q4	2/14/2020	186	0.0%	46,105	12/31/2019